Journal articles
Kartawinata M; Lin WY; Jebson B; O'Brien K; Ralph E; Welsh E; Restuadi R; Rosser EC; Deakin CT; Wedderburn LR; Wallace C, 2025, 'Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis', Annals of the Rheumatic Diseases, 84, pp. 1412 - 1424, http://dx.doi.org/10.1016/j.ard.2025.03.007
Peckham H; Radziszewska A; Sikora J; de Gruijter NM; Restuadi R; Kartawinata M; Martin-Gutierrez L; Robinson GA; Deakin CT; Wedderburn LR; Jury EC; Butler G; Chambers ES; Rosser EC; Ciurtin C, 2025, 'Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes', Journal of Experimental Medicine, 222, http://dx.doi.org/10.1084/jem.20241253
Lin J; Milder TY; Deakin CT; de Oliveira Costa J; Havard A; Neuen BL; Buckley NA; Brieger D; Greenfield JR; Jun M; Day RO; Pearson SA; Falster MO, 2025, 'Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study', Diabetes Research and Clinical Practice, 224, pp. 112242, http://dx.doi.org/10.1016/j.diabres.2025.112242
Radziszewska A; Peckham H; Restuadi R; Kartawinata M; Moulding D; De Gruijter N; Robinson G; Deakin C; Wilkinson M; Wedderburn L; Jury E; Rosser E; Ciurtin C, 2025, 'TYPE I INTERFERON AND MITOCHONDRIAL DYSFUNCTION ARE ASSOCIATED WITH DYSREGULATED CYTOTOXIC CD8+ T CELL RESPONSES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS', The Journal of Rheumatology, 52, pp. 81.1 - 81, http://dx.doi.org/10.3899/jrheum.2025-0390.pv001
Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson SA; Falster MO, 2025, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018-22', European Heart Journal Quality of Care and Clinical Outcomes, 11, pp. 259 - 270, http://dx.doi.org/10.1093/ehjqcco/qcae068
Lin WY; Kartawinata M; Jebson BR; Restuadi R; Peckham H; Radziszewska A; Deakin C; Ciurtin C; Wedderburn LR; Wallace C, 2025, 'Penalised regression improves imputation of cell-type specific expression using RNA-seq data from mixed cell populations compared to domain-specific methods', Plos Computational Biology, 21, http://dx.doi.org/10.1371/journal.pcbi.1012859
Littlejohn G; Anbumurali N; O'Sullivan C; Smith T; Racunica T; Pentony P; Jayaweera S; Girgis L; Smyth CM; Deakin CT, 2025, 'The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset', International Journal of Rheumatic Diseases, 28, http://dx.doi.org/10.1111/1756-185X.70123
Radziszewska A; Peckham H; Restuadi R; Kartawinata M; Moulding D; De Gruijter NM; Robinson GA; Butt M; Deakin CT; Wilkinson MGL; Wedderburn LR; Jury EC; Rosser EC; Ciurtin C, 2025, 'Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+T cell responses in juvenile systemic lupus erythematosus', Clinical and Experimental Immunology, 219, http://dx.doi.org/10.1093/cei/uxae127
Deakin CT; Littlejohn GO; Griffiths H; Ciciriello S; O'Sullivan C; Smith T; Youssef P; Bird P, 2024, 'Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings', Internal Medicine Journal, 54, pp. 795 - 801, http://dx.doi.org/10.1111/imj.16296
Syntakas AEK; Nguyen HD; Restuadi R; Jebson BR; Alexiou V; Marshall LR; Ralph E; Brien KO; Cancemi D; Peckham H; Radziszewska A; De Gruijter N; Hall GT; Castellano S; Ciurtin C; Deakin CT; Rosser E; Wedderburn LR; Kartawinata M; Wilkinson MGL, 2024, 'OA34 Unravelling the role of B cells and interferon dysregulation in juvenile dermatomyositis', Rheumatology, 63, http://dx.doi.org/10.1093/rheumatology/keae163.034
Ciciriello S; Littlejohn G; Treuer T; Gibson KA; Haladyj E; Youssef P; Bird P; O'Sullivan C; Smith T; Deakin CT, 2024, 'Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL Dataset', CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 42, pp. 1763 - 1772
Ciciriello S; Littlejohn G; O’Sullivan C; Smith T; Deakin CT, 2023, 'Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset', Clinical Rheumatology, 42, pp. 2971 - 2980, http://dx.doi.org/10.1007/s10067-023-06681-x
Ciciriello S; Littlejohn G; Treuer T; Gibson KA; Haladyj E; Youssef P; Bird P; O'Sullivan C; Smith T; Deakin CT, 2023, 'Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set', Acr Open Rheumatology, 5, pp. 345 - 353, http://dx.doi.org/10.1002/acr2.11577
Nott K; Nott V; Lever E; Deakin C; Galloway J; Fisher C; Compeyrot-Lacassagne S, 2023, 'Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients', Journal of Rheumatology, 50, pp. 924 - 933, http://dx.doi.org/10.3899/jrheum.220164
Oliveira T; Ylldlrlm R; Deakin C; Isenberg D, 2023, 'Rituximab in myositis: where are we now? A survey of current usage', Rheumatology United Kingdom, 62, pp. E211 - E212, http://dx.doi.org/10.1093/rheumatology/kead010
Deakin CT; De Stavola BL; Littlejohn G; Griffiths H; Ciciriello S; Youssef P; Mathers D; Bird P; Smith T; O'Sullivan C; Freeman T; Segelov D; Hoffman D; Seaman SR, 2023, 'Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia', JAMA Network Open, 6, pp. E2320851, http://dx.doi.org/10.1001/jamanetworkopen.2023.20851
Li Wilkinson MG; Moulding D; McDonnell TCR; Orford M; Wincup C; Ting JYJ; Otto GW; Restuadi R; Kelberman D; Papadopoulou C; Castellano S; Eaton S; Deakin CT; Rosser EC; Wedderburn LR, 2023, 'Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis', Annals of the Rheumatic Diseases, 82, pp. 658 - 669, http://dx.doi.org/10.1136/ard-2022-223469
Tymms K; O'Sullivan C; Smith T; Littlejohn G; Freeman T; Hoffman D; Segelov D; Griffiths H; Ciciriello S; Youssef P; Mathers D; Deakin CT, 2023, 'A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience', Frontiers in Digital Health, 4, http://dx.doi.org/10.3389/fdgth.2022.1074931
Greenan-Barrett J; Aston S; Deakin CT; Ciurtin C, 2023, 'The impact of immunocompromise on outcomes of COVID-19 in children and young people—a systematic review and meta-analysis', Frontiers in Immunology, 14, http://dx.doi.org/10.3389/fimmu.2023.1159269
Ciurtin C; Greenan- Barett J; Aston S; Deakin C, 2023, 'AB1333 THE IMPACT OF IMMUNOCOMPROMISE ON OUTCOMES OF COVID-19 IN CHILDREN AND YOUNG PEOPLE - A SYSTEMATIC REVIEW AND META-ANALYSIS', Scientific Abstracts, pp. 1897.1 - 1897, http://dx.doi.org/10.1136/annrheumdis-2023-eular.2552
Littlejohn G; Anbumurali N; Bird P; Youssef P; Osullivan C; Smith T; Sumpton D; Kane B; Mcgeachie A; Spiers S; Deakin C, 2023, 'DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET', ANNALS OF THE RHEUMATIC DISEASES, 82, pp. 1785 - 1785, http://dx.doi.org/10.1136/annrheumdis-2023-eular.3359
Littlejohn G; Anbumurali N; Osullivan C; Smith T; Racunica T; Pentony P; Jayaweera S; Girgis L; Deakin C, 2023, 'THE RELATIONSHIP BETWEEN PATIENT-REPORTED QUALITY OF LIFE AND PHYSICIAN-DERIVED CLINICAL OUTCOMES IN RHEUMATOID ARTHRITIS: AN ANALYSIS FROM THE AUSTRALIAN OPAL DATASET', ANNALS OF THE RHEUMATIC DISEASES, 82, pp. 327 - 327, http://dx.doi.org/10.1136/annrheumdis-2023-eular.1895
Shipa MR; Heyer N; Mansoor R; Deakin CT; Madenidou AV; Bouraioui A; Fisher C; Leandro M; Ciurtin C; Sen D, 2022, 'Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years', Seminars in Arthritis and Rheumatism, 55, http://dx.doi.org/10.1016/j.semarthrit.2022.152038
Deakin CT; Bowes J; Rider LG; Miller FW; Pachman LM; Sanner H; Rouster-Stevens K; Mamyrova G; Curiel R; Feldman BM; Huber AM; Reed AM; Schmeling H; Cook CG; Marshall LR; Ll Wilkinson MG; Eyre S; Raychaudhuri S; Wedderburn LR, 2022, 'Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis', Human Molecular Genetics, 31, pp. 2471 - 2481, http://dx.doi.org/10.1093/hmg/ddac019
Youssef P; Ciciriello S; Ngian GS; Aw J; Kane B; Osullivan C; Smith T; Deakin C; Littlejohn G, 2022, 'EVOLVING MECHANISM OF ACTION PREFERENCE FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS OF THE OPAL DATASET', ANNALS OF THE RHEUMATIC DISEASES, 81, pp. 831 - 831, http://dx.doi.org/10.1136/annrheumdis-2022-eular.1494
Ll Wilkinson MG; Deakin CT; Papadopoulou C; Eleftheriou D; Wedderburn LR, 2021, 'JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology', Pediatric Rheumatology, 19, http://dx.doi.org/10.1186/s12969-021-00637-8
Deakin CT; Cornish GH; Ng KW; Faulkner N; Bolland W; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson BR; Wilkinson MGLL; Marshall LR; O'Brien K; Rosser EC; Radziszewska A; Peckham H; Patel H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan CF; Spyer MJ; Gamblin SJ; McCauley J; Nastouli E; Levin M; Cherepanov P; Ciurtin C; Wedderburn LR; Kassiotis G, 2021, 'Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases', Med, 2, pp. 1093 - 1109.e6, http://dx.doi.org/10.1016/j.medj.2021.08.001
Deakin CT; Papadopoulou C; McCann LJ; Martin N; Al-Obaidi M; Compeyrot-Lacassagne S; Pilkington CA; Tansley SL; McHugh NJ; Wedderburn LR; De Stavola BL, 2021, 'Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models', Rheumatology United Kingdom, 60, pp. 1891 - 1901, http://dx.doi.org/10.1093/rheumatology/keaa497
Doudouliaki T; Papadopoulou C; Deakin CT, 2021, 'Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis', Current Rheumatology Reports, 23, http://dx.doi.org/10.1007/s11926-021-00990-3
Wilkinson MGL; Wu W; O'Brien K; Deakin CT; Wedderburn LR; Livermore P, 2021, 'A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective', Rheumatology Advances in Practice, 5, http://dx.doi.org/10.1093/rap/rkab058
Riddell V; Mcmorrow F; Oldroyd A; Deakin C; Lamb J; Chinoy H; Wedderburn L; Bagby S; Mchugh N; Tansley S, 2021, 'A KEY TIF1Γ EPITOPE MAY FACILITATE THE IDENTIFICATION OF PATIENTS AT HIGHEST RISK OF CANCER ASSOCIATED MYOSITIS', ANNALS OF THE RHEUMATIC DISEASES, 80, pp. 369 - 370, http://dx.doi.org/10.1136/annrheumdis-2021-eular.964
Deakin C; Littlejohn G; Griffiths H; Smith T; Osullivan C; Bird P, 2021, 'MODELLING OF DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES TREATED WITH ETANERCEPT ORIGINATOR OR BIOSIMILAR AS FIRST-LINE BIOLOGIC IN AN AUSTRALIAN REAL-WORLD DATASET', ANNALS OF THE RHEUMATIC DISEASES, 80, pp. 547 - 547, http://dx.doi.org/10.1136/annrheumdis-2021-eular.2265
Ciciriello S; Smith T; Osullivan C; Tymms K; Youssef P; Mathers D; Deakin C; Griffiths H; Littlejohn G, 2021, 'PATTERNS OF JANUS KINASE INHIBITOR CYCLING FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN REAL-WORLD CLINICAL PRACTICE: AN ANALYSIS OF THE OPAL DATASET', ANNALS OF THE RHEUMATIC DISEASES, 80, pp. 330 - 331, http://dx.doi.org/10.1136/annrheumdis-2021-eular.2256
Tymms K; Smith T; Deakin C; Freeman T; Hoffman D; Segelov D; Griffiths H; Ciciriello S; Youssef P; Mathers D; Osullivan C; Littlejohn G, 2021, 'THE DEVELOPMENT OF A NOVEL EPRO DELIVERY SYSTEM TO MEASURE PATIENT QUALITY OF LIFE IN ROUTINE CLINICAL CARE: AN ANALYSIS OF 5 YEARS OF EXPERIENCE', ANNALS OF THE RHEUMATIC DISEASES, 80, pp. 1015 - 1016, http://dx.doi.org/10.1136/annrheumdis-2021-eular.2253
Peckham H; de Gruijter NM; Raine C; Radziszewska A; Ciurtin C; Wedderburn LR; Rosser EC; Webb K; Deakin CT, 2020, 'Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission', Nature Communications, 11, http://dx.doi.org/10.1038/s41467-020-19741-6
Campanilho-Marques R; Deakin CT; Simou S; Papadopoulou C; Wedderburn LR; Pilkington CA; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Andrews M; Riley P; McGovern A; Cuthbert V; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Howman R; Wyatt S; Jackson G; Wood M; Amin T; Vanrooyen V; Burton D; Turner L; Hanson S; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Boyle R; Blyth E; Friswell M; Foster H; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Sandhu K; Dandy T; Hasson N; Al-Obadi M; Varnier G; Lacassagne S; Maillard S; Stone L; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri L; Beard L; Arnold K; Glackin Y; Simou S; Almeida B; Nistala K; Marques R; Khaosut P; Dowle S; Yasin S; Boros C; Wilkinson M; Piper C; Johnson-Moore C; Marshall L; O'Brien K; Robinson E; Murray K; Ciurtin C, 2020, 'Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients', Arthritis Research and Therapy, 22, http://dx.doi.org/10.1186/s13075-020-02164-5
Wienke J; Bellutti Enders F; Lim J; Mertens JS; van den Hoogen LL; Wijngaarde CA; Yeo JG; Meyer A; Otten HG; Fritsch-Stork RDE; Kamphuis SSM; Hoppenreijs EPAH; Armbrust W; van den Berg JM; Hissink Muller PCE; Tekstra J; Hoogendijk JE; Deakin CT; de Jager W; van Roon JAG; van der Pol WL; Nistala K; Pilkington C; de Visser M; Arkachaisri T; Radstake TRDJ; van der Kooi AJ; Nierkens S; Wedderburn LR; van Royen-Kerkhof A; van Wijk F, 2019, 'Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation', Arthritis and Rheumatology, 71, pp. 1377 - 1390, http://dx.doi.org/10.1002/art.40881
Yasin SA; Schutz PW; Deakin CT; Sag E; Varsani H; Simou S; Marshall LR; Tansley SL; McHugh NJ; Holton JL; Wedderburn LR; Jacques TS; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Foster H; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; ord S; Pilkington C; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Kassoumeri L; Beard L; Arnold K; Glackin Y; Almeida B; Nistala K; Marques R; Dowle S; Papadopoulou C; Johnson-Moore C; Robinson E; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; McMahon AM; Chisem H; Kingshott R; Wilkinson N; Inness E; Kendall E; Mayers D; Etherton R; Miller D; Bailey K, 2019, 'Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features', Neuropathology and Applied Neurobiology, 45, pp. 495 - 512, http://dx.doi.org/10.1111/nan.12528
Rothwell S; Chinoy H; Lamb JA; Miller FW; Rider LG; Wedderburn LR; McHugh NJ; Mammen AL; Betteridge ZE; Tansley SL; Bowes J; Vencovský JI; Deakin CT; Dankó K; Vidya L; Selva-O'Callaghan A; Pachman LM; Reed AM; Molberg Y; Benveniste O; Mathiesen PR; Radstake TRDJ; Doria A; De Bleecker J; Lee AT; Hanna MG; Machado PM; Ollier WE; Gregersen PK; Padyukov L; O'Hanlon TP; Cooper RG; Lundberg IE, 2019, 'Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups', Annals of the Rheumatic Diseases, 78, pp. 996 - 1002, http://dx.doi.org/10.1136/annrheumdis-2019-215046
Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS, 2019, 'Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis', Neuropathology and Applied Neurobiology, 45, pp. 410 - 420, http://dx.doi.org/10.1111/nan.12498
van Dijkhuizen EP; Deakin CT; Wedderburn LR; De Iorio M, 2019, 'Modelling disease activity in juvenile dermatomyositis: A Bayesian approach', Statistical Methods in Medical Research, 28, pp. 35 - 49, http://dx.doi.org/10.1177/0962280217713233
Webb K; Peckham H; Radziszewska A; Menon M; Oliveri P; Simpson F; Deakin CT; Lee S; Ciurtin C; Butler G; Wedderburn LR; Ioannou Y, 2019, 'Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2018.03167
Wienke J; Deakin CT; Wedderburn LR; van Wijk F; van Royen-Kerkhof A, 2018, 'Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.02951
Ting JYJ; Deakin CT; Rosser EC; Wilkinson M; Wedderburn L, 2018, 'O1 Investigating mitochondrial dysfunction in juvenile dermatomyositis', Rheumatology, 57, http://dx.doi.org/10.1093/rheumatology/key273
Johnson CR; Glackin Y; Chaplin H; Wedderburn LR; Pilkington C; Papadopoulou C; Deakin CT; Wilkinson M; Marshall LR; Hibberd Y; Heard C; Soponkanaporn S, 2018, 'P12 JDM Family Day: Bringing together young people and their families to share experiences of juvenile dermatomyositis (JDM) and provide a positive support network', Rheumatology, 57, http://dx.doi.org/10.1093/rheumatology/key273.014
van Dijkhuizen EHP; De Iorio M; Wedderburn LR; Deakin CT; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood PT; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Foster PH; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Pilkington C; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri ML; Beard ML; Arnold MK; Glackin Y; Simou S; Almeida B; Nistala K; Marques R; Dowle S; Papadopoulou C; Yasin S; Johnson-Moore C; Robinson E; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; McMahon AM; Chisem H; Kingshott R; Wilkinson N; Inness E; Kendall E; Mayers D; Etherton R; Miller D; Bailey K; Clinch J; Fineman N; Pluess-Hall H; Vallance L; Akeroyd L, 2018, 'Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: A prospective, longitudinal, multicenter cohort study', Arthritis Research and Therapy, 20, http://dx.doi.org/10.1186/s13075-018-1687-8
Piper CJM; Wilkinson MGL; Deakin CT; Otto GW; Dowle S; Duurland CL; Adams S; Marasco E; Rosser EC; Radziszewska A; Carsetti R; Ioannou Y; Beales PL; Kelberman D; Isenberg DA; Mauri C; Nistala K; Wedderburn LR; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Foster H; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Pilkington C; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri L; Beard L; Arnold K; Glackin Y; Simou S; Almeida B; Marques R; Papadopoulou C; Johnson-Moore C; Robinson E; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; McMahon AM; Chisem H; Kingshott R; Wilkinson N, 2018, 'CD19+CD24hiCD38hi B cells are expanded in juvenile dermatomyositis and exhibit a pro-inflammatory phenotype after activation through toll-like receptor 7 and interferon-α', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.01372
Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Foster H; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri L; Beard L; Arnold K; Glackin Y; Almeida B; Nistala K; Yasin S; Marques R; Dowle S; Papadopoulou C; Johnson-Moore C; Robinson E; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; McMahon AM; Chisem H; Kingshott R; Wilkinson N; Inness E; Kendall E; Mayers D; Etherton R; Miller D; Bailey K; Clinch J; Fineman N; Pluess-Hall H; Vallance L; Akeroyd L, 2018, 'Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling', Arthritis and Rheumatology, 70, pp. 785 - 793, http://dx.doi.org/10.1002/art.40418
Soponkanaporn S; Deakin CT; Marshall LR; Simou S; Wedderburn LR, 2017, '3. Investigating the association between serum inflammation-related proteins and muscle histopathological severity in juvenile dermatomyositis', Rheumatology, 56, http://dx.doi.org/10.1093/rheumatology/kex390.003
Binns EL; Moraitis E; Maillard S; Tansley S; McHugh N; Jacques TS; Wedderburn LR; Pilkington C; Yasin SA; Nistala K; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Clive Ryder ; Scott J; Thomas B; Southwood PT; Al-Abadi E; Sue Wyatt ; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Joyce Davidson ; Janet Gardner-Medwin ; Martin N; Ferguson S; Waxman L; Browne M; Mark Friswell ; Foster PH; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Helen Venning ; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Professor Lucy Wedderburn ; Hasson N; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri ML; Beard ML; Arnold MK; Glackin Y; Simou S; Almeida B; Marques R; Deakin C; Dowle S; Papadopoulou C; Johnson-Moore C; Robinson E; Kevin Murray ; John Ioannou ; Suffield L; Muthana Al-Obaidi ; Lee H; Leach S; Smith H; Anne-Marie McMahon ; Chisem H; Kingshott R; Nick Wilkinson ; Inness E; Kendall E; Mayers D; Etherton R; Miller D; Bailey K; Jacqui Clinch ; Fineman N, 2017, 'Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature', Pediatric Rheumatology, 15, http://dx.doi.org/10.1186/s12969-017-0205-x
Back to profile page
https://orcid.org/0000-0002-7044-5801